Saturated fatty alcohol
Treatment of herpes simplex labialis
Target
HSV1 envelope glycoprotein
Structure map
map07044
Antiviral agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06BB Antivirals
D06BB11 Docosanol
D03884 Docosanol (USAN)
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Herpesvirus glycoprotein
D03884 Docosanol (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03884
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03884
Rx-to-OTC switch list in the USA [br08315.html]
D03884
Other DBs
CAS:
30303-65-2
PubChem:
17397968
LigandBox:
D03884
KCF data
ATOM 23
1 C1a C 16.5900 -15.7500
2 C1b C 18.0124 -15.0500
3 C1b C 19.2249 -15.7500
4 C1b C 20.4373 -15.0500
5 O1a O 21.6497 -15.7500
6 C1b C 18.0124 -15.0500
7 C1b C 19.2249 -15.7500
8 C1b C 18.0124 -15.0500
9 C1b C 19.2249 -15.7500
10 C1b C 18.0124 -15.0500
11 C1b C 19.2249 -15.7500
12 C1b C 18.0124 -15.0500
13 C1b C 19.2249 -15.7500
14 C1b C 18.0124 -15.0500
15 C1b C 19.2249 -15.7500
16 C1b C 18.0124 -15.0500
17 C1b C 19.2249 -15.7500
18 C1b C 18.0124 -15.0500
19 C1b C 19.2249 -15.7500
20 C1b C 18.0124 -15.0500
21 C1b C 19.2249 -15.7500
22 C1b C 18.0124 -15.0500
23 C1b C 19.2249 -15.7500
BOND 22
1 4 5 1
2 1 2 1
3 2 3 1
4 3 6 1
5 6 7 1
6 7 8 1
7 8 9 1
8 9 10 1
9 10 11 1
10 11 12 1
11 12 13 1
12 13 14 1
13 14 15 1
14 15 16 1
15 16 17 1
16 17 18 1
17 18 19 1
18 19 20 1
19 20 21 1
20 21 22 1
21 22 23 1
22 23 4 1
BRACKET 1 17.7100 -16.5200 17.7100 -14.8400
1 19.5300 -14.8400 19.5300 -16.5200
1 10
ORIGINAL 1 2 3
REPEAT 1 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
1 22 23